CTOs on the Move

Astellas Gene Therapies

www.astellasgenetherapies.com

 
Astellas Gene Therapies is an Astellas Center of Excellence developing genetic medicines with the potential to deliver transformative value for patients. Based on an innovative scientific approach and industry leading internal manufacturing capability and expertise, we are currently exploring three gene therapy modalities: gene replacement, exon skipping gene therapy, and vectorized RNA knockdown and will also advance additional Astellas gene therapy programs toward clinical investigation. We are based in San Francisco, with manufacturing and laboratory facilities in South San Francisco and Sanford, North Carolina.
  • Number of Employees: 250-1000
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Strenumed Inc

Strenumed Inc is a Ventura, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Siemic

Siemic is a San Jose, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pacific Bridge Medical

Pacific Bridge Medical is a Bethesda, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HOWARD INSTRUMENTS

HOWARD INSTRUMENTS is a Tuscaloosa, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Novadaq

Enabling surgeons with clinically-relevant, innovative fluorescence imaging solutions to enhance the lives of patients and their surgeons, while reducing health care costs, is Novadaq’s global mission. SPY fluorescence imaging technology provides surgeons with real-time visualization, leading to improved outcomes and reduced costs without exposing the patient to harmful ionizing radiation or contrast dye toxicity. More than 130 peer-reviewed publications demonstrate that the use of SPY during complex surgery, leads to fewer post-operative complications and lower hospital costs. The SPY Imaging System is United States Food and Drug Administration (“FDA”) 510(k) cleared for use in seven surgical specialties. The endoscopic version of SPY called PINPOINT®, combines the capabilities of SPY Imaging with high definition (“HD”) visible light visualization offered by conventional endoscopes. Our unique business model of partnering with market-leading companies to drive adoption of our fluorescence imaging technology, while building our own commercial infrastructure is the cornerstone of our corporate strategy for growth.